Literature DB >> 9834623

Establishment and characterization of in vitro decidualization in normal human endometrial stromal cells.

K Mizuno1, T Tanaka, N Umesaki, S Ogita.   

Abstract

We established and characterized a novel experimental model of in vitro decidualization in normal human endometrial stromal cells. In a comparison of decidualization induction, 8-Br-cAMP showed the strongest ability to induce decidualization in stromal cells among four inducers examined: progesterone, medroxyprogesterone acetate, prostaglandin E2, and 8-Br-cAMP. The effects of 8-Br-cAMP were enhanced by prostaglandin E2 but not altered by medroxyprogesterone acetate. Both progesterone and medroxyprogesterone acetate activity was so weak that it took more than 2 weeks to induce in vitro decidualization. These results suggest that there are two independent decidualization signals in the in vitro decidualization, a cAMP-mediated signaling pathway and a progesterone receptor-mediated signaling pathway, and that cAMP-inducers are major factors in decidualization in vivo. Differential expressions of three membrane aminopeptidases on the stromal cells during the decidualization are also discussed.

Entities:  

Mesh:

Year:  1998        PMID: 9834623

Source DB:  PubMed          Journal:  Osaka City Med J        ISSN: 0030-6096


  2 in total

1.  The production of interleukin-11 and decidualization are compromised in endometrial stromal cells derived from patients with infertility.

Authors:  Natalia Karpovich; Petra Klemmt; Jung Hye Hwang; J Enda McVeigh; John K Heath; David H Barlow; Helen J Mardon
Journal:  J Clin Endocrinol Metab       Date:  2004-12-21       Impact factor: 5.958

2.  Chronic endometritis modifies decidualization in human endometrial stromal cells.

Authors:  Di Wu; Fuminori Kimura; Luyi Zheng; Mitsuaki Ishida; Yoko Niwa; Kimiko Hirata; Akie Takebayashi; Akiko Takashima; Kentaro Takahashi; Ryoji Kushima; Guangmei Zhang; Takashi Murakami
Journal:  Reprod Biol Endocrinol       Date:  2017-03-04       Impact factor: 5.211

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.